3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
24
Thoracic
19
Breast
19
Gynecologic
17
Head & Neck
10
Genitourinary
5
Sarcoma
3
Dermatologic
3
Tumor-Agnostic
1
Other neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Endocrine
1
Classical hematology
1
CNS
1
Conditions
Anemia
1
Interventions
Cyclophosphamide
8
Whole-Body Irradiation
6
fludarabine
5
fludarabine phosphate
4
Tacrolimus
4
Mycophenolic Acid
4
Melphalan
4
Busulfan
3
luspatercept
2
Vorinostat
2
Thiotepa
2
Sirolimus
2
Peripheral Blood Stem Cell Transplantation
2
Lenalidomide
2
Granulocyte Colony-Stimulating Factor
2
Biopsy
2
Azacitidine
2
AP 1903 reagent
2
venetoclax
1
ribociclib
1
palbociclib
1
olaparib
1
ibrutinib
1
hetrombopag
1
edoxaban
1
decitabine and cedazuridine drug combination
1
apixaban
1
acalabrutinib
1
abemaciclib
1
Valganciclovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Taxes
×
Classical hematology
×
Clear all
NCT06018883
2025-08-07
PTCA199-3
Fudan University
Phase 3
Active not recruiting
100 enrolled